Literature DB >> 27554195

Factors associated with use of falls risk-increasing drugs among patients of a geriatric oncology outpatient clinic in Australia: a cross-sectional study.

Justin P Turner1,2, Hanna E Tervonen3, Sepehr Shakib4, Nimit Singhal5,6, Robert Prowse7, J Simon Bell1,2.   

Abstract

Older people with cancer are at increased risk of falling. Falls risk-increasing drugs (FRIDs), comprising psychotropics and medications that cause orthostatic hypotension, are a potentially modifiable risk factor for falls. The objective of this study was to determine the prevalence and factors associated with use of FRIDs in older people with cancer. Patients aged ≥70 years who presented to a hospital outpatient clinic between January 2009 and July 2010 were included in the study. Information on current medication use, falls in previous 6 months, and frailty criteria was collected. Multinomial logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (CIs) for factors associated with levels of FRID use. Overall, 76.1% (n = 293) of 383 patients used FRIDs. This comprised psychotropics (31.2%, n = 120) and medications causing orthostatic hypotension (69.9%, n = 269). In total, 24.0% (n = 92) patients reported falling in the previous 6 months. Risk factors for falling were associated with use of psychotropics but not orthostatic hypotension drugs. Patients with a history of falls had increased odds of using psychotropics (≥3 psychotropics; OR 13.50; 95%CI, 2.64-68.94). Likewise, frail patients had increased odds of using psychotropics (≥3 psychotropics; OR 27.78; 95%CI, 6.06-127.42). Risk factors for falling were associated with the use of psychotropics. This suggests that clinicians either do not recognize or underestimate the contribution of medications to falls in this high-risk patient group. Further efforts are needed to rationalize medication regimens at the time of patients' first presentation to outpatient oncology services.
© 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  aged; clinical audit; clinical safety; evaluation; falls; falls risk-increasing drugs; frail elderly; geriatric oncology

Mesh:

Substances:

Year:  2016        PMID: 27554195     DOI: 10.1111/jep.12624

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  2 in total

1.  A Systematic Review and Meta-Analyses of the Association Between Anti-Hypertensive Classes and the Risk of Falls Among Older Adults.

Authors:  Hui Ting Ang; Ka Keat Lim; Yu Heng Kwan; Pui San Tan; Kai Zhen Yap; Zafirah Banu; Chuen Seng Tan; Warren Fong; Julian Thumboo; Truls Ostbye; Lian Leng Low
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

2.  Falls in older adults with cancer: an updated systematic review of prevalence, injurious falls, and impact on cancer treatment.

Authors:  T M Wildes; S Alibhai; S Sattar; K Haase; S Kuster; M Puts; S Spoelstra; C Bradley
Journal:  Support Care Cancer       Date:  2020-07-16       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.